155 related articles for article (PubMed ID: 24938224)
1. The HYPERFlax trial for determining the anti-HYPERtensive effects of dietary flaxseed in newly diagnosed stage 1 hypertensive patients: study protocol for a randomized, double-blinded, controlled clinical trial.
Caligiuri SP; Penner B; Pierce GN
Trials; 2014 Jun; 15():232. PubMed ID: 24938224
[TBL] [Abstract][Full Text] [Related]
2. Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α-linolenic acid-induced inhibition of soluble epoxide hydrolase.
Caligiuri SP; Aukema HM; Ravandi A; Guzman R; Dibrov E; Pierce GN
Hypertension; 2014 Jul; 64(1):53-9. PubMed ID: 24777981
[TBL] [Abstract][Full Text] [Related]
3. Potent antihypertensive action of dietary flaxseed in hypertensive patients.
Rodriguez-Leyva D; Weighell W; Edel AL; LaVallee R; Dibrov E; Pinneker R; Maddaford TG; Ramjiawan B; Aliani M; Guzman R; Pierce GN
Hypertension; 2013 Dec; 62(6):1081-9. PubMed ID: 24126178
[TBL] [Abstract][Full Text] [Related]
4. The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral artery disease: rationale and design of the FLAX-PAD randomized controlled trial.
Leyva DR; Zahradka P; Ramjiawan B; Guzman R; Aliani M; Pierce GN
Contemp Clin Trials; 2011 Sep; 32(5):724-30. PubMed ID: 21616170
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized, crossover trial protocol of whole hemp seed protein and hemp seed protein hydrolysate consumption for hypertension.
Samsamikor M; Mackay D; Mollard RC; Aluko RE
Trials; 2020 Apr; 21(1):354. PubMed ID: 32326966
[TBL] [Abstract][Full Text] [Related]
6. Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes.
Taylor CG; Noto AD; Stringer DM; Froese S; Malcolmson L
J Am Coll Nutr; 2010 Feb; 29(1):72-80. PubMed ID: 20595648
[TBL] [Abstract][Full Text] [Related]
7. Dietary Flaxseed Reduces Central Aortic Blood Pressure Without Cardiac Involvement but Through Changes in Plasma Oxylipins.
Caligiuri SP; Rodriguez-Leyva D; Aukema HM; Ravandi A; Weighell W; Guzman R; Pierce GN
Hypertension; 2016 Oct; 68(4):1031-8. PubMed ID: 27528063
[TBL] [Abstract][Full Text] [Related]
8. The effect of flaxseed supplementation in processed foods on serum fatty acids and enterolactone.
Tarpila S; Aro A; Salminen I; Tarpila A; Kleemola P; Akkila J; Adlercreutz H
Eur J Clin Nutr; 2002 Feb; 56(2):157-65. PubMed ID: 11857049
[TBL] [Abstract][Full Text] [Related]
9. Does pragmatically structured outpatient dietary counselling reduce sodium intake in hypertensive patients? Study protocol for a randomized controlled trial.
Ruzicka M; Ramsay T; Bugeja A; Edwards C; Fodor G; Kirby A; Magner P; McCormick B; van der Hoef G; Wagner J; Hiremath S
Trials; 2015 Jun; 16():273. PubMed ID: 26081765
[TBL] [Abstract][Full Text] [Related]
10. Effects of flaxseed supplements on blood pressure: A systematic review and meta-analysis of controlled clinical trial.
Ursoniu S; Sahebkar A; Andrica F; Serban C; Banach M;
Clin Nutr; 2016 Jun; 35(3):615-25. PubMed ID: 26071633
[TBL] [Abstract][Full Text] [Related]
11. Effect of α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: A randomized placebo-controlled trial in untreated (pre-)hypertensive individuals.
Joris PJ; Draijer R; Fuchs D; Mensink RP
Clin Nutr; 2020 Aug; 39(8):2413-2419. PubMed ID: 31818531
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of alpha-linolenic acid from flaxseed diets as a function of the age of the subject.
Patenaude A; Rodriguez-Leyva D; Edel AL; Dibrov E; Dupasquier CM; Austria JA; Richard MN; Chahine MN; Malcolmson LJ; Pierce GN
Eur J Clin Nutr; 2009 Sep; 63(9):1123-9. PubMed ID: 19584895
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults.
Cornish SM; Chilibeck PD; Paus-Jennsen L; Biem HJ; Khozani T; Senanayake V; Vatanparast H; Little JP; Whiting SJ; Pahwa P
Appl Physiol Nutr Metab; 2009 Apr; 34(2):89-98. PubMed ID: 19370038
[TBL] [Abstract][Full Text] [Related]
14. Flaxseed for hypertension: implications for blood pressure regulation.
Caligiuri SP; Edel AL; Aliani M; Pierce GN
Curr Hypertens Rep; 2014 Dec; 16(12):499. PubMed ID: 25342643
[TBL] [Abstract][Full Text] [Related]
15. Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies (GYMNs study): comparison of three different blood pressure measurement methods: study protocol for a randomized controlled trial.
Cheng HM; Sung SH; Chen CH; Yu WC; Yang SM; Guo CY; Chuang SY; Chiang CE
Trials; 2019 May; 20(1):265. PubMed ID: 31077229
[TBL] [Abstract][Full Text] [Related]
16. The effect of flaxseed dose on circulating concentrations of alpha-linolenic acid and secoisolariciresinol diglucoside derived enterolignans in young, healthy adults.
Edel AL; Patenaude AF; Richard MN; Dibrov E; Austria JA; Aukema HM; Pierce GN; Aliani M
Eur J Nutr; 2016 Mar; 55(2):651-663. PubMed ID: 25808116
[TBL] [Abstract][Full Text] [Related]
17. Effect of flax addition on the flavor profile and acceptability of bagels.
Aliani M; Ryland D; Pierce GN
J Food Sci; 2012 Jan; 77(1):S62-70. PubMed ID: 22260132
[TBL] [Abstract][Full Text] [Related]
18. Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model.
Ingram AJ; Parbtani A; Clark WF; Spanner E; Huff MW; Philbrick DJ; Holub BJ
Am J Kidney Dis; 1995 Feb; 25(2):320-9. PubMed ID: 7847360
[TBL] [Abstract][Full Text] [Related]
19. Influence of Flaxseed Lignan Supplementation to Older Adults on Biochemical and Functional Outcome Measures of Inflammation.
Di Y; Jones J; Mansell K; Whiting S; Fowler S; Thorpe L; Billinsky J; Viveky N; Cheng PC; Almousa A; Hadjistavropoulos T; Alcorn J
J Am Coll Nutr; 2017; 36(8):646-653. PubMed ID: 28922068
[TBL] [Abstract][Full Text] [Related]
20. Effects of flaxseed on blood pressure, body mass index, and total cholesterol in hypertensive patients: A randomized clinical trial.
Toulabi T; Yarahmadi M; Goudarzi F; Ebrahimzadeh F; Momenizadeh A; Yarahmadi S
Explore (NY); 2022; 18(4):438-445. PubMed ID: 34119421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
